Sort
82,697 grants matching “vaccine development”
Elucidating the role of TSR glycosylation in Plasmodium parasites
$844,019Kristian Edward Swearingen · Institute For Systems Biology · R01 · FY2022 · AI
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors
$843,841Keith Magnus Sigel · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection
$843,809Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2017 · AI
Development of novel lipid nanoparticles for nucleic acids delivery in the brain
$843,806Yizhou Dong · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · EB
Optimization of chimeric multi-stage immunogens for malaria vaccine development
$843,761Alberto Moreno · Emory University · R56 · FY2014 · AI
Influenza pathogenesis in pregnancy
$843,733Kristina M Adams Waldorf · University Of Washington · R01 · FY2024 · AI
TASK D15: FILARIASIS RESEARCH REAGENT CENTER
$843,650Christian Hiendel · University Of Georgia · N01 · FY2017 · AI
Immune Responses to Malaria and HIV Infection and Immunization
$843,628Kenneth D Stuart · Seattle Biomedical Research Institute · U19 · FY2018 · AI
Human antibodies as broad alphavirus immunotherapeutics
$843,620Jonathan R. Lai · Albert Einstein College Of Medicine · R01 · FY2025 · AI
ESTABLISHMENT/MAINTENANCE OF BIOMEDICAL RESEARCH COLONY
$843,593University Of Louisiana At Lafayette · U42 · FY2002 · RR
Development of the Next Generation of Conjugate Vaccines
$843,503Luc Teyton · Scripps Research Institute, The · R01 · FY2021 · AI
A new humanized mouse model to study HBV gene editing
$843,440Keith R Jerome · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Chlamydial Immunity and Vaccine Development
$843,162Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
$843,131Louis J. Picker · Oregon Health & Science University · R01 · FY2015 · AI
Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice
$843,126Daniel Kulp · Wistar Institute · R01 · FY2023 · AI
Clinical trials employing cancer vaccine combination therapies
$843,113James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Harnessing Abs specific for immunogenic and conserved Env epitopes to protect against HIV
$843,043Catarina E Hioe · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · AI
Natural History of Pre-diabetic Autoimmunity (DAISY)
$843,037Marian J. Rewers · University Of Colorado Denver · R37 · FY2008 · DK
Containing Bioterrorist and Emerging Infectious Diseases
$842,982Ira M Longini · Fred Hutchinson Cancer Research Center · U01 · FY2010 · GM
Towards a Vaccine to Prevent Toxoplasmosis
$842,962Rima L McLeod · University Of Chicago · U01 · FY2009 · AI
Plasma-Generated Hydroxyl Radicals for Analysis of Three-Dimensional Structures in Protein Therapeutics
$842,961Faraz Choudhury · Immuto Scientific, Inc. · R44 · FY2023 · GM
University of Pittsburgh Clinical and Translational Science Institute
$842,907Steven E Reis · University Of Pittsburgh At Pittsburgh · UL1 · FY2020 · TR
Task A47: Development of Ferret and Hamster Reagents for Immunological Studies
$842,859Saul Tzipori · Tufts University Boston · N01 · FY2021 · AI
Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study
$842,800Maria De Las Mercedes Perez Rodriguez · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · MH
Core B: Testing and Biorepository
$842,780Eugene M. Oltz · Ohio State University · U54 · FY2020 · CA